I am mindful of how life altering a diagnosis of cancer can be, not just for the patient, but all the loved ones in their life as well. Patients and families rightly deserve, and will always get the very best of us in intelligence and compassion, along with access to state of the art treatment which is continually improving long-term outcomes.
Mitul Gandhi, MDMitul Gandhi, M.D., completed his undergraduate studies at Rutgers University, graduating magna cum laude with a Bachelor of Arts in Molecular Biology and Biochemistry, and earning minors in Classical Humanities and Political Science. He subsequently earned his medical degree from Rutgers Robert Wood Johnson Medical School, where he was honored with the Robert Wood Johnson Foundation Research Award among other distinctions.
Following medical school, Dr. Gandhi completed his internship and residency in Internal Medicine at the University of Michigan Health System. He then pursued his Hematology and Medical Oncology fellowship at Northwestern University, where he was selected as the Chief Fellow in his final year. During his fellowship, Dr. Gandhi was active in clinical research, with a particular interest in high-risk lymphoma. His contributions led to presentations at major national meetings, and he was recognized with the American Society of Hematology’s Abstract Achievement Award in 2013, along with publications in high-impact journals such as Blood.
Since joining Virginia Cancer Specialists, Dr. Gandhi has become co-director of the Virginia Cancer Specialists Research Institute and is the Director of the Hematology Trials Program. He is the primary investigator on numerous studies in leukemia, lymphoma, and multiple myeloma. Additionally, he sits on the national US Oncology Hematology Committee, is part of the Multiple Myeloma Executive Committee, and regularly has research presented at major national meetings. Dr. Gandhi’s expertise and dedication have earned him recognition as a Top Doctor in publications such as Northern Virginia Magazine, Washingtonian, and Castle Connolly.
In his spare time, Dr. Gandhi enjoys spending time with his wife and three children, coaching soccer, and planning their next family trip.
Northwestern University Feinberg School of Medicine, Medical Oncology and Hematology
University of Michigan Health System
Rutgers Robert Wood Johnson Medical School
University of Michigan Health System
Rutgers University
Malignant hematology (leukemia, lymphoma, myeloma), lung cancer, breast cancer & Clinical Trials
English
February 1, 2024
February 1, 2023
February 1, 2022
February 1, 2021
February 1, 2020
February 1, 2019
February 1, 2018
January 1, 2024
July 1, 2024
November 1, 2023
November 1, 2021
November 1, 2020
November 1, 2019
November 1, 2018
NHL Patients and Nurses in the US Prefer Subcutaneous Rituximab Injection Versus Intravenous Rituximab Infusion: A Real-World Study
Safety and Antitumor Activity Study Evaluating Loncastuximab Tesirine and Rituximab Versus Immunochemotherapy in Diffuse Large B-Cell Lymphoma
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Pancreatitis in patients treated with Brentuximab Vedotin: A previously unrecognized serious adverse
Read MorePredicting benefit from imatinib. Are we close? Leukemia and Lymphoma.
Read MoreTargeted treatment of head and neck squamous cell carcinoma: potential of lapatinib.
Read MoreImpact of Induction Regimen and Consolidative Stem Cell Transplantation in Double Hit Lymphoma (DHL)
Read MoreAssociation of implantable defibrillator therapy risk with body mass index in systolic heart failure
Read MoreBrentuximab Vedotin in Patients with Relapsed HIV-Related Lymphoma
Read More
Hours of Operation
Monday through Friday
8:30 a.m. to 5:00 p.m.
Phone:
(571) 350-8400
Fax:
(571) 222-2202
Address:
7901 Lake Manassas Drive
Gainesville, VA 20155
Hours of Operation
Monday through Friday
8:30 a.m. to 5:00 p.m
Phone:
(571) 350-8400
Fax:
(703) 280-9596
Address:
8613 US-29
Fairfax, VA 22031